ICD-11 code : 3A20.0;
Preferred Label : Autoimmune haemolytic anaemia, warm type;
ICD-11 definition : Autoimmune hemolytic anemia (AIHA) is an autoimmune disorder in which various types
of auto-antibodies are directed against red blood cells causing their survival to
be shortened and resulting in hemolytic anemia. AIHA can be primary (idiopathic),
secondary to infection or associated with diseases such as B-cell lymphomas, other
systemic or organ-specific autoimmune diseases, Hodgkin's disease, hepatitis or primary
immunodeficiencies, or, in the case of drug-induced AIHA, caused by a reaction to
drugs.;
ICD-11 synonym : warm type secondary haemolytic anaemia; autoimmune haemolytic anaemia; Autoimmune haemolytic disease warm type; AHA - [autoimmune haemolytic anaemia]; other autoimmune haemolytic anaemias; warm type hemolytic anaemia; hemolytic anaemia due to warm antibody; warm type autoimmune haemolytic disease; symptomatic warm type hemolytic anaemia; warm AIHA; warm autoimmune hemolytic anaemia; Autoimmune haemolytic anaemia due to warm antibodies; warm type symptomatic haemolytic anaemia; warm AIHA - [autoimmune haemolytic anaemia];
ICD-11 acronym : AHA;
ICD-11 inclusion : secondary autoimmune hemolytic anaemia; acquired autoimmune haemolytic anaemia; secondary warm type hemolytic anaemia; Lederer anaemia; secondary Dyke Young type anaemia; Dyke Young type anaemia; acute Lederer haemolytic anaemia; symptomatic autoimmune hemolytic anaemia;
Origin ID : 880772122;
UMLS CUI : C0002880;
Automatic exact mappings (from CISMeF team)
- Currated CISMeF NLP mapping
- ICD-10 Mapping
- Semantic type(s)
- UMLS correspondences (same concept)
- Validated automatic mappings to NTBT
Autoimmune hemolytic anemia (AIHA) is an autoimmune disorder in which various types
of auto-antibodies are directed against red blood cells causing their survival to
be shortened and resulting in hemolytic anemia. AIHA can be primary (idiopathic),
secondary to infection or associated with diseases such as B-cell lymphomas, other
systemic or organ-specific autoimmune diseases, Hodgkin's disease, hepatitis or primary
immunodeficiencies, or, in the case of drug-induced AIHA, caused by a reaction to
drugs.
